BRCA Mutation

Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries

The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors

The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation.

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer

The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer

Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion

Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors

Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors

MEASUREMENT OF CIRCULATING MUTATION BURDEN

Prophylactic Prostatectomy for Prostate Cancer (PPPC)

Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer

Robotic Nipple Sparing Mastectomy with Immediate Reconstruction

Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage

MiniLap Vs Standard Laparoscopy in Prophylactic Bilateral Salpingo-oophorectomy in BRCA-Mutated Patients

Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation

Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer

Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations